NMC Health (LON:NMC) had its price target lifted by Jefferies Group from GBX 3,085 ($41.85) to GBX 3,291 ($44.64) in a research note released on Monday morning. They currently have a hold rating on the stock.
A number of other brokerages have also recently weighed in on NMC. JPMorgan Chase cut NMC Health to a neutral rating and boosted their price target for the stock from GBX 2,730 ($37.03) to GBX 3,270 ($44.36) in a research report on Wednesday, January 24th. Berenberg Bank reaffirmed a buy rating and issued a GBX 4,000 ($54.26) price target on shares of NMC Health in a research report on Monday, January 29th. Finally, Barclays initiated coverage on NMC Health in a research report on Monday, April 23rd. They issued an overweight rating and a GBX 4,250 ($57.65) price target for the company.
Shares of LON:NMC opened at GBX 3,592 ($48.72) on Monday. NMC Health has a fifty-two week low of GBX 1,726 ($23.41) and a fifty-two week high of GBX 3,558 ($48.26).
The business also recently declared a dividend, which will be paid on Tuesday, July 10th. Shareholders of record on Thursday, June 14th will be given a GBX 13 ($0.18) dividend. The ex-dividend date is Thursday, June 14th. This represents a dividend yield of 0.38%. This is a boost from NMC Health’s previous dividend of $10.60.
About NMC Health
NMC Health Plc provides healthcare services in the United Arab Emirates and internationally. It operates through two businesses, NMC Healthcare and NMC Trading. The company owns and manages approximately 135 healthcare facilities that include hospitals, medical centers, long term care facilities, day surgery centers, fertility centers, and home health services providers.
Receive News & Ratings for NMC Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NMC Health and related companies with MarketBeat.com's FREE daily email newsletter.